Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

Hepatology

Volumn 47, Issue 6, 2008, Pages 1846-1855

  Vanwolleghem, Thomas ^a   Bukh, Jens ^b,c,d   Meuleman, Philip ^a   Desombere, Isabelle ^a   Meunier, Jean Christophe ^b,e   Alter, Harvey ^f   Purcell, Robert H ^b   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITÉ DE LYON   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; UROKINASE; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; HEPATITIS C; HEPATITIS C VIRUS; LOW DRUG DOSE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRUS STRAIN; ANIMAL; BLOOD; DISEASE MODEL; HUMAN; IMMUNOLOGY; METHODOLOGY; MOUSE MUTANT; PATHOGENICITY;

ANIMALS; ANTIBODIES, VIRAL; CHIMERA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MICE, SCID; RNA, VIRAL;

EID: 46249125111     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22244     Document Type: Article

References (31)

1. Davis GL, Nelson DR, Terrault N, Pruett TL, Schiano TD, Fletcher CV, et al. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl 2005;11:941-949.
2. Willems B, Ede M, Marotta P, Wall W, Greig P, Lilly L, et al. Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot study. J Hepatol 2002;36:32.
3. Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996;173:822-828.
4. Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur-Kaspa R, et al. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver Transplantation for HCV: results of a phase 2 randomized study. Liver Transpl 2006;12:1381-1389.
5. Yu MY, Bartosch B, Zhang P, Guo ZP, Renzi PM, Shen LM, et al. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc Natl Acad Sci U S A 2004;101:7705-7710.
6. Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 2004;101:10149-10154.
7. Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, Alter H, et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudoparticles and enhancement of infectivity by apolipoprorein C1. Proc Natl Acad Sci USA 2005;102:4560-4565.
8. Farci P, Alter HJ, Wong DC, Millet RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994;91:7792-7796.
9. Lavillette D, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005;79:6023-6034.
10. Pestka JM, Zeisel MB, Blaser E, Schurmann P, Bartosch B, Cosset FL, et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007;104:6025-6030.
11. Flint M, Logvinoff C, Rice CM, McKeating JA. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J Virol 2004;78:6875-6882.
12. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197:633-642.
13. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001;7:927-933.
14. Meuleman P, Libbrechr L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. HEPATOLOGY 2005;41:847-856.
15. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultuted in vitro. Proc Natl Acad Sci U S A 2006;103:3805-3809.
16. Feinstone SM, Alter HJ, Dienes HP, Shimizu Y, Popper H, Blackmore D, et al. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 1981;144:588-598.
17. Steyaert S, Heyndrickx L, Verhoye L, Vermoesen T, Donners H, Fransen K, et al. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients. Antiviral Res 2007;75:129-138.
18. Meuleman P, Vanlandschoot P, Leroux-Roels G. A simple and tapid method to determine the zygosity of uPA-transgenic SCID mice. Biochem Biophys Res Commun 2003;308:375-378.
19. Tournoy KG, Depraetere S, Pauwels RA, Leroux-Roels GG. Mouse strain and conditioning tegimen determine survival and function of human leucocytes in immunodeficient mice. Clin Exp Immunol 2000;119:231-239.
20. Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 1997;94:8738-8743.
21. Sakai A, Takikawa S, Thimme R, Meuniet JC, Spangenberg HC, Govindarajan S, et al. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol 2007;81:7208-7219.
22. Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, et al. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 2003;100:14199-14204.
23. von Hahn T, Yoon JC, Alter H, Rice CM, Rehetmann B, Balfe P, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007; 132:667-678.
24. Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. HEPATOLOGY 2000;32:618-625.
25. Zuckier LS, Georgescu L, Chang CJ, Scharff MD, Morrison SL. The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer 1994;73:794-799.
26. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998;282:103-107.
27. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
28. Gale M Jr, Foy EM. Evasion of intracellular host defence by hepatitis C vitus. Nature 2005;436:939-945.
29. Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, et al. Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog 2006;2:e59.
30. Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol 2002;2:706-713.
31. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M Jr, et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 2007;104:5848-5853.